The complement component C5a is present in human coronary lesions <i>in vivo</i> and induces the expression of MMP‐1 and MMP‐9 in human macrophages <i>in vitro</i>
Walter S. Speidl(University of Applied Sciences St Pölten), Johann Wojta(Medical University of Vienna), Gerald Maurer(European Society of Radiology), Katharina M. Katsaros(Medical University of Vienna), Kurt Huber(Sigmund Freud Privatuniversität Wien), Gerhard Bauriedel(University of Bonn), Randolph Hutter(Mount Sinai Hospital), Juan J. Badimón(Icahn School of Medicine at Mount Sinai), Stefan P. Kasd(Ludwig Boltzmann Institute for Cardiovascular Research), Christoph Kaun(University of Vienna)
Cited by 95
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877